US Patent Issued to B3AR THERAPEUTICS on Oct. 7 for "Solabegron zwitterion and uses thereof" (New Jersey, Pennsylvania, New York Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,026, issued on Oct. 7, was assigned to B3AR THERAPEUTICS INC. (Palo Alto, Calif.).

"Solabegron zwitterion and uses thereof" was invented by Raymond E. Stevens (West Chester, Pa.), Dalian Zhao (Fanwood, N.J.) and Bingidimi Itute Mobele (Altamont, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This application relates to solabegron zwitterion useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to pharmaceutical compositions and methods of treatment utilizing the solabegron zwitterion for treating lower urinary tract symptoms. This applicati...